tiprankstipranks
PHARMABEES
Nippon India Nifty Pharma ETF Units Exchange Traded Fund
Advertisement

IN:PHARMABEES ETF Technical Analysis

Compare

Summary of all the Indicators

Summary
Buy
13Bullish
3Neutral
4Bearish
Oscillators
Sell
3Bullish
3Neutral
4Bearish
Moving Averages
Strong Buy
10Bullish
0Neutral
0Bearish
Nippon India Nifty Pharma ETF Units Exchange Traded Fund’s (PHARMABEES) Moving Averages Convergence Divergence (MACD) indicator is 0.37, suggesting Nippon India Nifty Pharma ETF Units Exchange Traded Fund is a Sell.
Nippon India Nifty Pharma ETF Units Exchange Traded Fund’s (PHARMABEES) 20-Day exponential moving average is 25.50, making it a Buy.
Nippon India Nifty Pharma ETF Units Exchange Traded Fund’s (PHARMABEES) 50-Day exponential moving average is 24.91, making it a Buy.

Nippon India Nifty Pharma ETF Units Exchange Traded Fund (PHARMABEES) Pivot Points

Jul 05, 2026, 12:31 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
25.61
25.70
25.84
25.93
26.07
26.16
26.30
Fibonacci
25.70
25.79
25.84
25.93
26.02
26.07
26.16

Nippon India Nifty Pharma ETF Units Exchange Traded Fund (PHARMABEES) Moving Averages

Jul 05, 2026, 12:31 AM
Period
Simple
Exponential
MA5
26.05Buy
26.06Buy
MA10
25.77Buy
25.81Buy
MA20
25.33Buy
25.50Buy
MA50
24.92Buy
24.91Buy
MA100
24.00Buy
24.32Buy
Nippon India Nifty Pharma ETF Units Exchange Traded Fund’s (PHARMABEES) 10-Day exponential moving average is 25.81, making it a Buy.
Nippon India Nifty Pharma ETF Units Exchange Traded Fund’s (PHARMABEES) 100-Day exponential moving average is 24.32, making it a Buy.
Nippon India Nifty Pharma ETF Units Exchange Traded Fund’s (PHARMABEES) 50-day simple moving average is 24.92, creating a Buy signal.
Nippon India Nifty Pharma ETF Units Exchange Traded Fund’s (PHARMABEES) 100-day simple moving average is 24.00, creating a Buy signal.

Nippon India Nifty Pharma ETF Units Exchange Traded Fund (PHARMABEES) Technical Analysis

Jul 05, 2026, 12:31 AM
Name
Value
Action
RSI (14)
73.18
Sell
STOCH (9,6)
73.44
Neutral
STOCHRSI (14)
77.69
Neutral
MACD (12,26)
0.37
Sell
ADX (14)
19.82
Buy
Williams %R
-7.44
Sell
CCI (14)
123.26
Sell
ATR (14)
0.74
-
Ultimate Oscillator
57.43
Neutral
ROC
5.88
Buy
Nippon India Nifty Pharma ETF Units Exchange Traded Fund’s (PHARMABEES) Relative Strength Index (RSI) is 73.18, creating a Sell signal.
Nippon India Nifty Pharma ETF Units Exchange Traded Fund’s (PHARMABEES) Trend Strength Indicator (ADX) is 19.82, creating a Buy signal.
Nippon India Nifty Pharma ETF Units Exchange Traded Fund’s (PHARMABEES) Commodity Channel Index (CCI) is 123.26, creating a Sell signal.
Nippon India Nifty Pharma ETF Units Exchange Traded Fund’s (PHARMABEES) Price Rate of Change (ROC) is 5.88, creating a Buy signal.

FAQ

Is PHARMABEES a Buy, Hold, or Sell?
Based on PHARMABEES’s technical indicators, PHARMABEES is a Buy.
    What is PHARMABEES’s RSI (14)?
    PHARMABEES’s RSI (14) is 73.18, which suggests PHARMABEES is a Sell.
      What is PHARMABEES’s MACD?
      PHARMABEES’s MACD is 0.37, which suggests PHARMABEES is a Sell.
        What is PHARMABEES’s 5-day moving average?
        PHARMABEES’s 5-day moving average is 26.05, which suggests PHARMABEES is a Buy.
          What is PHARMABEES’s 20-day moving average?
          PHARMABEES 20-day moving average is 25.33, which suggests PHARMABEES is a Buy.
            What is PHARMABEES’s 50-day moving average?
            PHARMABEES’s 50-day moving average is 24.92, which suggests PHARMABEES is a Buy.
              What is PHARMABEES’s 200-day moving average?
              Currently, no data Available
              What is PHARMABEES’s Williams % R (14)?
              PHARMABEES’s Williams % R (14) is -7.44, which suggests PHARMABEES is a Sell.
                What is PHARMABEES’s CCI (14)?
                PHARMABEES’s CCI (14) is 123.26, which suggests PHARMABEES is a Sell.
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis
                  Advertisement